Diamonds and Dogs

4/17/25

Easy Diamond and Dog today. Eli Lilly (LLY) is soaring over 15% after the pharmaceutical company said it successfully had completed a Phase 3 trial for its new orforglipron pill. Data collected during the trial showed that the pill was as safe as injectable GLP-1 medicines currently on the market. As one analyst mentioned, this pill may be easier to manufacture and sell as the injectable drugs on the market have struggled with some manufacturing issues.

UnitedHealth (UNH) is down 23%, worst day in 25 years after missing earnings by 9 cents, missing sales targets as revenue rose 9.8%. Then lowered 2025 guidance due to higher-than-expected costs for people enrolled in Medicare plans. The problem is with higher utilization across senior populations and the patient mix and revenue profile of Optum Health. UnitedHealth does expect improvements in profitability in the second half of the year.